The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Risk of Clostridium difficile Infection With Acid Suppressing Drugs and Antibiotics: Meta-Analysis
Abstract
OBJECTIVES: Several studies have raised concern regarding the possible association between proton-pump inhibitors (PPIs) and Clostridium difficile infection (CDI). We aimed to perform a systematic review of incident and recurrent CDI in PPI users, and to evaluate the relative impact of concurrent antibiotic use, or switching acid suppression to histamine-2-receptor antagonists (H2RAs). METHODS: We searched MEDLINE and EMBASE from inception to December 2011 for controlled observational studies that reported on the risk of CDI with and without PPI use. We performed random effects meta-analysis and assessed statistical heterogeneity using the I(2) statistic. RESULTS: We included 42 observational studies (30 case-control, 12 cohort) totalling 313,000 participants overall. Pooled analysis of 39 studies showed a statistically significant association between PPI use and risk of developing CDI, odds ratio (OR) 1.74 (95% confidence interval (CI) 1.47-2.85, P<0.001, I(2)=85%) compared with non-users. A pooled analysis of three studies showed a significant associated risk of recurrent CDI associated with PPIs, OR 2.51 (95% CI 1.16-5.44, P=0.005, I(2)=78%). Subgroup analysis failed to fully clarify the source of the substantial statistical heterogeneity. Adjusted indirect comparison demonstrated that use of H2RAs as an alternative carried a lower-risk OR 0.71 (95% CI 0.53-0.97) compared with PPIs. Conversely, concomitant use of PPI and antibiotics conferred a greater-risk OR 1.96 (95% CI 1.03-3.70) above that of PPIs alone. For PPI and antibiotics, the Rothman's synergy index was 1.36 and attributable proportion of risk from interaction 0.19, indicating an increased risk from interaction beyond the effects of each drug alone. CONCLUSIONS: Despite the substantial statistical and clinical heterogeneity, our findings indicate a probable association between PPI use and incident and recurrent CDI. This risk is further increased by concomitant use of antibiotics and PPI, whereas H2RAs may be less harmful.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Bucher, H. C., Guyatt, G. H., Griffith, L. E., & Walter, S. D. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(97)00049-8 · Cited by 2,052
Loo, V. G., Poirier, L., Miller, M. A., Oughton, M., Libman, M. D., Michaud, S., Bourgault, A.-M., Nguyen, T., Frenette, C., Kelly, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051639 · Cited by 1,946
Calculating measures of biological interaction
Andersson, T., Alfredsson, L., Källberg, H., Zdravkovic, S., & Ahlbom, A. (2005) · European Journal of Epidemiology · doi:10.1007/s10654-005-7835-x · Cited by 1,498
Warny, M., Pepin, J., Fang, A., Killgore, G., Thompson, A., Brazier, J., Frost, E., & McDonald, L. C. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67420-x · Cited by 1,430
Clopidogrel with or without Omeprazole in Coronary Artery Disease
Bhatt, D. L., Cryer, B. L., Contant, C. F., Cohen, M., Lanas, A., Schnitzer, T. J., Shook, T. L., Lapuerta, P., Goldsmith, M. A., Laine, L., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1007964 · Cited by 1,240
The appropriateness of asymmetry tests for publication bias in meta-analyses: A large survey
Ioannidis, J. P. A., & Trikalinos, T. A. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.060410 · Cited by 1,052
Pepin, J., Saheb, N., Coulombe, M.-A., Alary, M.-E., Corriveau, M.-P., Authier, S., Leblanc, M., Rivard, G., Bettez, M., Primeau, V., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/496986 · Cited by 995
Davies, H. T. O., Crombie, I. K., & Tavakoli, M. (1998) · BMJ · doi:10.1136/bmj.316.7136.989 · Cited by 984
Host and Pathogen Factors for Clostridium difficile Infection and Colonization
Loo, V. G., Bourgault, A.-M., Poirier, L., Lamothe, F., Michaud, S., Turgeon, N., Toye, B., Beaudoin, A., Frost, E. H., Gilca, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1012413 · Cited by 797
Systematic review of the risk of enteric infection in patients taking acid suppression
Leonard, J., Marshall, J. K., & Moayyedi, P. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01275.x · Cited by 633
Muto, C. A., Pokrywka, M., Shutt, K., Mendelsohn, A. B., Nouri, K., Posey, K., Roberts, T., Croyle, K., Krystoflak, S., Patel-Brown, S., et al. (2005) · Infection Control & Hospital Epidemiology · doi:10.1086/502539 · Cited by 619
Narrative Review: The New Epidemic of Clostridium difficile–Associated Enteric Disease
Bartlett, J. G. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-10-200611210-00008 · Cited by 599
Dial, S. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1040876 · Cited by 577
Bavishi, C., & DuPont, H. L. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04874.x · Cited by 480
Reasons or excuses for avoiding meta-analysis in forest plots
Ioannidis, J. P. A., Patsopoulos, N. A., & Rothstein, H. R. (2008) · BMJ · doi:10.1136/bmj.a117 · Cited by 457
Iatrogenic Gastric Acid Suppression and the Risk of Nosocomial Clostridium difficile Infection
Howell, M. D. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.89 · Cited by 437
Song, F., Loke, Y. K., Walsh, T., Glenny, A.-M., Eastwood, A. J., & Altman, D. G. (2009) · BMJ · doi:10.1136/bmj.b1147 · Cited by 395
Self-citationThorens, J., Froehlich, F., Schwizer, W., Saraga, E., Bille, J., Gyr, K., Duroux, P., Nicolet, M., Pignatelli, B., Blum, A. L., et al. (1996) · Gut · doi:10.1136/gut.39.1.54 · Cited by 339
Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea
Cunningham, R., Dale, B., Undy, B., & Gaunt, N. (2003) · Journal of Hospital Infection · doi:10.1016/s0195-6701(03)00088-4 · Cited by 331
Bliss, D. Z., Johnson, S., Savik, K., Clabots, C. R., Willard, K., & Gerding, D. N. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-12-199812150-00004 · Cited by 298
Proton Pump Inhibitors and Risk for Recurrent Clostridium difficile Infection
Linsky, A. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.73 · Cited by 276
Stress ulcer prophylaxis in the new millennium: A systematic review and meta-analysis
Marik, P. E., Vasu, T., Hirani, A., & Pachinburavan, M. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181f17adf · Cited by 248
Underlying Disease Severity as a Major Risk Factor for Nosocomial Clostridium difficile Diarrhea
Kyne, L., Sougioultzis, S., McFarland, L. V., & Kelly, C. P. (2002) · Infection Control & Hospital Epidemiology · doi:10.1086/501989 · Cited by 242
Aseeri, M., Schroeder, T., Kramer, J., & Zackula, R. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01975.x · Cited by 236
Dial, S. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.060284 · Cited by 218
Deshpande, A., Pant, C., Pasupuleti, V., Rolston, D. D. K., Jain, A., Deshpande, N., Thota, P., Sferra, T. J., & Hernandez, A. V. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.09.030 · Cited by 213
Zedtwitz-Liebenstein, K., Wenisch, C., Patruta, S., Parschalk, B., Daxböck, F., & Graninger, W. (2002) · Critical Care Medicine · doi:10.1097/00003246-200205000-00026 · Cited by 206
Fluoroquinolone Use and Clostridium difficile–associated Diarrhea
McCusker, M. E., Harris, A. D., Perencevich, E., & Roghmann, M.-C. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0906.020385 · Cited by 200
Yoshida, N., Yoshikawa, T., Tanaka, Y., Fujita, N., Kassai, K., Naito, Y., & Kondo, M. (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.014s1074.x · Cited by 190
Bajaj, J. S., Ananthakrishnan, A. N., Hafeezullah, M., Zadvornova, Y., Dye, A., McGinley, E. L., Saeian, K., Heuman, D., Sanyal, A. J., & Hoffmann, R. G. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.615 · Cited by 175
Baxter, R. P., Ray, G. T., & Fireman, B. H. (2007) · Infection Control and Hospital Epidemiology · doi:10.1086/524320 · Cited by 174
Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection
Dial, S., Kezouh, A., Dascal, A., Barkun, A., & Suissa, S. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.071812 · Cited by 166
Kuntz, J. L., Chrischilles, E. A., Pendergast, J. F., Herwaldt, L. A., & Polgreen, P. M. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-194 · Cited by 161
Lowe, D. O., Mamdani, M. M., Kopp, A., Low, D. E., & Juurlink, D. N. (2006) · Clinical Infectious Diseases · doi:10.1086/508453 · Cited by 156
Proton pump inhibitor therapy is a risk factor for Clostridium difficile ‐associated diarrhoea
YEARSLEY, K. A., GILBY, L. J., Ramadas, A., Kubiak, E., Fone, D. L., & Allison, M. C. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03015.x · Cited by 145
Dubberke, E. R. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.10.1092 · Cited by 141
A Hospital Outbreak of Diarrhea Due to an Emerging Epidemic Strain of Clostridium difficile
Kazakova, S. V. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.22.2518 · Cited by 117
Albumin, Length of Stay, and Proton Pump Inhibitors
Al-Tureihi, F. I. J., Hassoun, A., Wolf‐Klein, G. P., & Isenberg, H. D. (2005) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2005.01.003 · Cited by 116
McFarland, L. V., Clarridge, J. E., Beneda, H., & Raugi, G. J. (2007) · Clinical Infectious Diseases · doi:10.1086/522187 · Cited by 111
Proton pump inhibitors as a risk factor for recurrence ofClostridium-difficile-associated diarrhea
Kim, J. W. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i28.3573 · Cited by 110
Quinolone Use as a Risk Factor for Nosocomial Clostridium difficile-Associated Diarrhea
Yip, C., Loeb, M. B., Salama, S. E., Moss, L., & Olde, J. (2001) · Infection Control and Hospital Epidemiology · doi:10.1086/501954 · Cited by 105
Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection
TURCO, R., Martinelli, M., Miele, E., Roscetto, E., Pezzo, M. D., Greco, L., & Staiano, A. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04229.x · Cited by 104
Association of proton-pump inhibitors with outcomes inClostridium difficilecolitis
Cadle, R. M., Mansouri, M. D., Logan, N. D., Kudva, D. R., & Musher, D. M. (2007) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp060629 · Cited by 101
Occurrence and significance of gastric colonization during acid-inhibitory therapy
Williams, C. (2001) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2001.0191 · Cited by 100
Choudhry, M., Soran, H., & Ziglam, H. M. (2008) · QJM · doi:10.1093/qjmed/hcn035 · Cited by 99
Dalton, B., LYE‐MACCANNELL, T., Henderson, E. A., MacCannell, D., & Louie, T. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03924.x · Cited by 94
Agastya, G., West, B. C., & Callahan, J. M. (2000) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923970009016425 · Cited by 91
Gastric acid suppression does not promote clostridial diarrhoea in the elderly
Shah, S. (2000) · QJM · doi:10.1093/qjmed/93.3.175 · Cited by 88
Debast, S. B., Vaessen, N., Choudry, A., Wiegers-Ligtvoet, E. A. J., van den Berg, R. J., & Kuijper, E. J. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02713.x · Cited by 71
Clostridium difficile Among Hospitalized Patients Receiving Antibiotics A Case-Control Study
Modena, S., Bearelly, D., Swartz, K., & Friedenberg, F. K. (2005) · Infection Control and Hospital Epidemiology · doi:10.1086/502603 · Cited by 67
Jayatilaka, S. G., Shakov, R., Eddi, R., Bakaj, G., Baddoura, W., & DeBari, V. A. (2007) · PubMed · Cited by 65
Cunningham, R., & Dial, S. (2008) · Journal of Hospital Infection · doi:10.1016/j.jhin.2008.04.023 · Cited by 63
Stevens, V. W., Dumyati, G. K., Brown, J. E., & van Wijngaarden, E. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2198 · Cited by 56
Beaulieu, M., Williamson, D. R., Pichette, G., & Lachaîne, J. (2007) · Infection Control and Hospital Epidemiology · doi:10.1086/521664 · Cited by 54
Clostridium difficile infection in an endemic setting in the Netherlands
Hensgens, M. P. M., Goorhuis, A., van Kinschot, C. M. J., Crobach, M. J. T., Harmanus, C., & Kuijper, E. J. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-010-1127-4 · Cited by 50
Ingle, M., Deshmukh, A. M., Desai, D., Abraham, P., Joshi, A. G., Rodrigues, C. S., & Mankeshwar, R. (2011) · Indian Journal of Gastroenterology · doi:10.1007/s12664-011-0097-5 · Cited by 50
Postoperative Clostridium difficile-associated diarrhea
Southern, W. N., Rahmani, R., Aroniadis, O. C., Khorshidi, I., Thanjan, A., Ibrahim, C. B., & Brandt, L. J. (2010) · Surgery · doi:10.1016/j.surg.2009.11.021 · Cited by 46
Akhtar, A. J., & Shaheen, M. A. (2007) · PubMed · Cited by 31
Does PPI therapy predispose to Clostridium difficile infection?
Pant, C., Madonia, P. N., & Minocha, A. (2009) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.128 · Cited by 28
The Relationship between Inpatient Fluoroquinolone Use and Clostridium difficile-Associated Diarrhea
Novell, M. J., & Morreale, C. A. (2010) · Annals of Pharmacotherapy · doi:10.1345/aph.1m696 · Cited by 20
Linney, S., Fernandes, T., Einarson, T. R., Sengar, A., Walker, J. H., & Mills, A. (2010) · The Canadian Journal of Hospital Pharmacy · doi:10.4212/cjhp.v63i1.866 · Cited by 11
Cited by
McDonald, L. C., Gerding, D. N., Johnson, S., Bakken, J. S., Carroll, K. C., Coffin, S. E., Dubberke, E. R., Garey, K. W., Gould, C. V., Kelly, C., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix1085 · Cited by 2,690
Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections
Surawicz, C. M., Brandt, L. J., Binion, D. G., Ananthakrishnan, A. N., Curry, S. R., Gilligan, P. H., McFarland, L. V., Mellow, M., & Zuckerbraun, B. S. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.4 · Cited by 1,645
ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease
Katz, P. O., Dunbar, K. B., Schnoll-Sussman, F. H., Greer, K. B., Yadlapati, R., & Spechler, S. J. (2022) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001538 · Cited by 1,038
Proton pump inhibitors alter the composition of the gut microbiota
Jackson, M. A., Goodrich, J. K., Maxan, M.-E., Freedberg, D. E., Abrams, J. A., Poole, A. C., Sutter, J. L., Welter, D., Ley, R. E., Bell, J. T., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310861 · Cited by 895
Clostridium difficile infection
Smits, W. K., Lyras, D., Lacy, D. B., Wilcox, M. H., & Kuijper, E. J. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.20 · Cited by 853
Metadata
- Authors
- Kwok, C. S., Arthur, A. K., Anibueze, C. I., Singh, S., Cavallazzi, R., & Loke, Y. K.
- Venue
- American Journal of Gastroenterology
- Published
- 2012-07
- Volume
- 107
- Issue
- 7
- Pages
- 1011-1019
- ISSN
- 0002-9270 (ISSN-L)
- OpenAlex
- W2007982564
- Cited by
- 581
- References
- 64
- FWCI
- 32.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.